[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652905":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":15,"locations":23,"responsibleParty":47,"collaborators":7,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":7,"enrollmentInfo":59,"targetDuration":7,"studyType":62,"phases":7,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Centre Hospitalier de Colmar","OTHER",null,[9,13],{"name":10,"affiliation":11,"role":12},"Karine Demesmay","Hopitaux Civils de Colmar","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":11,"role":12},"Emilie Hutt",[16,20],{"name":10,"role":17,"phone":18,"phoneExt":7,"email":19},"CONTACT","+33 3 89 12 42 40","karine.demesmay@ch-colmar.fr",{"name":21,"role":17,"phone":22,"phoneExt":7,"email":7},"Magali Eyriey","+33 3 89 12 48 10",[24],{"facility":25,"status":26,"city":27,"state":7,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Hôpitaux Civils de Colmar","RECRUITING","Colmar","68024","France","FR",{"type":32,"coordinates":33},"Point",[34,35],7.35584,48.08078,{"lat":35,"lon":34},[38,41,44,46],{"name":10,"role":17,"phone":39,"phoneExt":40,"email":19},"+33389124963","+33",{"name":21,"role":17,"phone":42,"phoneExt":7,"email":43},"+33389124810","cellule-promotion@ch-colmar.fr",{"name":14,"role":45,"phone":7,"phoneExt":7,"email":7},"SUB_INVESTIGATOR",{"name":10,"role":12,"phone":7,"phoneExt":7,"email":7},{"type":48,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100652905","effect-of-aromatherapy-on-the-management-of-chemotherapy-induced-neuropathy-cin-100652905",false,"NCT07779135","Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN)","Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN) in Patients Receiving Taxane Therapy for Breast Cancer.","AROMA NEUROTAX","Inclusion Criteria:\n\n* Female patients with breast cancer\n* who have painful or bothersome CIN\n* occurring in the context of paclitaxel treatment (during or after treatment)\n* for whom conventional drug treatments provide insufficient relief (or are poorly tolerated or refused).\n* Age ≥ 18 years\n* Who, after receiving information, do not object to the use of their data for the purposes of this research\n\nExclusion Criteria:\n\n* Pre-existing neuropathy (e.g., due to diabetes)\n* Known allergy to an essential oil or a component of essential oils (e.g., linalool)\n* Presence of wounds on the affected areas\n* Refusal to use aromatherapy\n* Inability to complete the questionnaires","FEMALE","18 Years",{"count":60,"type":61},80,"ESTIMATED","OBSERVATIONAL","The main objective of this study is to describe the effect of an essential oil-based blend applied topically in the management of painful symptoms, sensory disturbances, or functional impairment caused by Chemotherapy-Induced Neuropathy (CIN) in breast cancer patients who have undergone paclitaxel treatment.",[65,66],"Breast Cancer","Neuropathic Pain in Cancer",[68,69,70],"Chemotherapy-Induced Neuropathy","Breast cancer","Aromatherapy","2026-08-20",{"date":73,"type":74},"2026-08-21","ACTUAL",{"date":76,"type":74},"2026-07-15",{"date":78,"type":61},"2027-09-15",{"name":5,"class":6},1]